Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Tagliani

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Clinical Microbiology|July 17, 2015
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter StudyElisa Tagliani, Andrea M Cabibbe, Paolo Miotto, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Scientific Reports|December 17, 2017
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national surveyElisa Tagliani, Mohamed Osman Hassan, Yacine Waberi, et al.
The European Respiratory Journal|August 1, 2020
Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot studyElisa Tagliani, Richard Anthony, Thomas A Kohl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 25, 2023
Update on the diagnosis of tuberculosisIrina Kontsevaya, Andrea Maurizio Cabibbe, Daniela Maria Cirillo, et al.
The Lancet. Infectious Diseases|August 25, 2022
Balancing access to BPaLM regimens and risk of resistanceAnnelies Van Rie, Timothy Walker, Bouke de Jong, et al.
Eclinicalmedicine|April 18, 2020
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countriesValérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, et al.
The European Respiratory Journal|September 18, 2020
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugsAgathe Jouet, Cyril Gaudin, Nelly Badalato, et al.
Plos One|November 1, 2017
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamideJean Claude Semuto Ngabonziza, Awa Ba Diallo, Elisa Tagliani, et al.
Scientific Data|April 15, 2025
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across ItalyArash Ghodousi, Angela Cannas, Elisa Tagliani, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Clinical Microbiology|July 17, 2015
Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter StudyElisa Tagliani, Andrea M Cabibbe, Paolo Miotto, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Scientific Reports|December 17, 2017
Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national surveyElisa Tagliani, Mohamed Osman Hassan, Yacine Waberi, et al.
The European Respiratory Journal|August 1, 2020
Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot studyElisa Tagliani, Richard Anthony, Thomas A Kohl, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 25, 2023
Update on the diagnosis of tuberculosisIrina Kontsevaya, Andrea Maurizio Cabibbe, Daniela Maria Cirillo, et al.
The Lancet. Infectious Diseases|August 25, 2022
Balancing access to BPaLM regimens and risk of resistanceAnnelies Van Rie, Timothy Walker, Bouke de Jong, et al.
Eclinicalmedicine|April 18, 2020
Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countriesValérie Schwœbel, Arnaud Trébucq, Zacharie Kashongwe, et al.
The European Respiratory Journal|September 18, 2020
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugsAgathe Jouet, Cyril Gaudin, Nelly Badalato, et al.
Plos One|November 1, 2017
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamideJean Claude Semuto Ngabonziza, Awa Ba Diallo, Elisa Tagliani, et al.
Scientific Data|April 15, 2025
Comprehensive Whole Genome Sequencing Dataset of Mycobacterium tuberculosis Strains Collected Across ItalyArash Ghodousi, Angela Cannas, Elisa Tagliani, et al.
Pageof 4